Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001288320-13-000001
Filing Date
2013-08-05
Accepted
2013-08-05 16:41:57
Documents
1
Effectiveness Date
2013-08-05
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10064
  Complete submission text file 0001288320-13-000001.txt   11264
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-200775 | Film No.: 131010656
SIC: 2834 Pharmaceutical Preparations